Updated UK Recommendations for HER2 assessment in breast cancer

Human epidermal growth factor receptor 2 (HER2) overexpression is present in approximately 15% of early invasive breast cancers, and is an important predictive and prognostic marker. The substantial benefits achieved with anti-HER2 targeted therapies in patients with HER2-positive breast cancer have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Pathol
Main Authors: Rakha, Emad A, Pinder, Sarah E, Bartlett, John M S, Ibrahim, Merdol, Starczynski, Jane, Carder, Pauline J, Provenzano, Elena, Hanby, Andrew, Hales, Sally, Lee, Andrew H S, Ellis, Ian O
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Best Practice
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4316916/
https://ncbi.nlm.nih.gov/pubmed/25488926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jclinpath-2014-202571
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados